Pharmaceutical Dose Form Grouper Without Basic Dose Form

736542009 |Pharmaceutical dose form (dose form)

(dose form)

900000000000073002 |Sufficiently defined by necessary conditions definition status (core metadata concept)|

• Exceptions:
  • Grouper concepts representing drug delivery systems will have Definition status = 900000000000074008 |Not sufficiently defined by necessary conditions definition status (core metadata concept)|

• Range: << 736480007 |Dose form release characteristic (release characteristic)|
• Cardinality: 0..*
  
  • While the allowed range is broader, the grouper concepts without basic dose form should have 1..1 |Has dose form release characteristic| attributes.

• Range: << 736479009 |Dose form intended site (intended site)
• Cardinality: 0..*
  
  • While the allowed range is broader, the grouper concepts without basic dose form should have 1..* |Has dose form intended site| attributes.

• Range: << 736665006 |Dose form administration method (administration method)
• Cardinality: 0..*
  • While the allowed range is broader, the grouper concepts without basic dose form should have 1..1 |Has dose form administration method| attributes.

For concepts with 736472000 |Has dose form administration method (attribute)| = 738996007 |Spray (administration method)|, use the following pattern for the FSN; align naming and case sensitivity with the FSN for the concept that is selected as the attribute value. For multiple intended sites, the intended sites must be in alphabetical order and separated by the word “or”.

• <Dose form release characteristic> <Dose form intended site FSN> <Dose form administration method> (dose form)

Example:

• Conventional release cutaneous spray (dose form)
• Conventional release nasal spray (dose form)
• Conventional release sublingual spray (dose form)

---------------

For concepts representing drops with 736472000 |Has dose form administration method (attribute)| = 738994005 |Instill (administration method)|, use the following pattern for the FSN; align naming and case sensitivity with the FSN for the concept that is selected as the attribute value. For multiple intended sites, the intended sites must be in alphabetical order and separated by the word “or”.

• <Dose form release characteristic> <Dose form intended site FSN> <Dose form administration method> (dose form)

Example:

• Conventional release nasal drops (dose form)
• Prolonged-release eye drops (dose form)

---------------

For concepts representing drug delivery systems, use the following pattern for the FSN; align naming and case sensitivity with the FSN for the concept that is selected as the attribute value. For multiple intended sites, the intended sites must be in alphabetical order and separated by the word “or”.

• <Dose form release characteristic> <Dose form intended site FSN> drug delivery system

Example:

• Prolonged-release intrauterine drug delivery system (dose form)
• Prolonged-release transdermal drug delivery system (dose form)

For concepts with 736472000 |Has dose form administration method (attribute)| = 738996007 |Spray (administration method)|, use the following pattern for the PT; align naming and case sensitivity with the PT for the concept that is selected as the attribute value. For multiple intended sites, the intended sites must be in alphabetical order and separated by the word “or”. Exclude <Dose form release characteristic> when = 736849007 |Conventional release (release characteristic)|.

• <Dose form release characteristic> <Dose form intended site FSN> <Dose form administration method>

Example:

• Cutaneous spray
• Nasal spray
• Sublingual spray

---------------

For concepts representing drops with 736472000 |Has dose form administration method (attribute)| = 738994005 |Instill (administration method)|, use the following pattern for the PT; align naming and case sensitivity with the PT for the concept that is selected as the attribute value. For multiple intended sites, the intended sites must be in alphabetical order and separated by the word “or”. Exclude <Dose form release characteristic> when = 736849007 |Conventional release (release characteristic)|.

• <Dose form release characteristic> <Dose form intended site FSN> <Dose form administration method>

Example:

• Nasal drops
• Prolonged-release eye drops

---------------

For concepts representing drug delivery systems, use the following pattern for the PT; align naming and case sensitivity with the PT for the concept that is selected as the attribute value. For multiple intended sites, the intended sites must be in alphabetical order and separated by the word “or”. Exclude <Dose form release characteristic> when = 736849007 |Conventional release (release characteristic)|.

• <Dose form release characteristic> <Dose form intended site FSN> drug delivery system

Example:

• Prolonged-release intrauterine drug delivery system (dose form)
• Prolonged-release transdermal drug delivery system (dose form)

A synonym matching the FSN is required; additional synonyms are not allowed unless explicitly identified as an exception in the Editorial Guidelines.

Exceptions:

• Synonyms with eye instead of ocular, ear instead of otic, or nose instead of nasal may be created